These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 7679806)

  • 1. Performance of hepatitis C virus (HCV) second-generation enzyme immunoassay (EIA) on blood samples that reacted in the first-generation HCV EIA.
    Tobler L; Lee SR; Busch MP
    Transfusion; 1993 Mar; 33(3):271-2. PubMed ID: 7679806
    [No Abstract]   [Full Text] [Related]  

  • 2. Low prevalence of hepatitis C virus infection among dentists in Taiwan.
    Kuo MY; Hahn LJ; Hong CY; Kao JH; Chen DS
    J Med Virol; 1993 May; 40(1):10-3. PubMed ID: 7685807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of antibody to hepatitis C virus by second-generation enzyme immunoassay.
    Chaudhary RK; Maclean C
    Am J Clin Pathol; 1993 Jun; 99(6):702-4. PubMed ID: 7686716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme immunoassays for anti-hepatitis C virus antibodies improved specificity and analytical sensitivity by combination of three different recombinant viral proteins in second generation tests.
    Prohaska W; Schroeter E; Kaars-Wiele P; Kleesiek K
    Eur J Clin Chem Clin Biochem; 1992 Jul; 30(7):397-404. PubMed ID: 1381965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of hepatitis C virus kits.
    Chaudhary RK; Frenette S; Mo T
    J Clin Microbiol; 1991 Nov; 29(11):2616-7. PubMed ID: 1723074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of clinical and laboratory aspects of antibody tests for detection of hepatitis C virus infection in blood donors and recipients from a low-risk population.
    MacDonald KL; Mills WA; Wood RC; Hanson M; Kline W; Bowman RJ; Polesky HF; Williams AE; Osterholm MT
    Transfusion; 1994 Mar; 34(3):202-8. PubMed ID: 8146891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity and sensitivity of 3rd generation EIA for detection of HCV antibodies among intravenous drug-users.
    Filice G; Patruno S; Campisi D; Chiesa A; Orsolini P; Debiaggi M; Bruno R; Tinelli M
    New Microbiol; 1993 Jan; 16(1):35-42. PubMed ID: 7682283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved detection of antibodies to hepatitis C virus in dialysis patients using a second-generation enzyme immunoassay.
    de Medina M; Ortiz C; Krenc C; Leete J; Vallari D; Hill M; LaRue S; Jimenez M; Anderson W; Schiff E
    Am J Kidney Dis; 1992 Dec; 20(6):589-91. PubMed ID: 1334368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgG interference in second generation enzymeimmunoassays for anti-hepatitis C virus antibodies.
    Borque L; Maside C; Rus A; Elena A; del Cura J; Gastañares MJ
    J Immunoassay; 1993 Sep; 14(3):183-9. PubMed ID: 7689081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of third-generation hepatitis C virus (HCV) enzyme immunoassay (EIA) to resolve second-generation HCV EIA-reactive and second-generation recombinant immunoblot assay-indeterminate blood samples: data to support current Food and Drug Administration guidance on HCV lookback.
    Busch MP; Tobler LH; Tegtmeier G; Polito A; Quan S; Hirschler NV; Dockter J; Giachetti C; Mimms L
    Transfusion; 2000 Jan; 40(1):10-4. PubMed ID: 10644806
    [No Abstract]   [Full Text] [Related]  

  • 11. A novel semi-automated paramagnetic microparticle based enzyme immunoassay for hepatitis C virus: its application to serologic testing.
    Todd J; Kink J; Leahy D; Preisel-Simmons B; Laska S; Wolff P; Jacobson P; Byrne R; Babler S; McCoy-Haman M
    J Immunoassay; 1992; 13(3):393-410. PubMed ID: 1324258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus in autoimmune liver disease in the UK: aetiological agent or artefact?
    Rowan BP; Smith A; Gleeson D; Hunt LP; Warnes TW
    Gut; 1994 Apr; 35(4):542-6. PubMed ID: 8174994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity of second-generation enzyme immunoassay for detection of hepatitis C virus infection among oncology patients.
    Macedo de Oliveira A; White KL; Beecham BD; Leschinsky DP; Foley BP; Dockter J; Giachetti C; Safranek TJ
    J Clin Virol; 2006 Jan; 35(1):21-5. PubMed ID: 15921955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lookback on donors who are repeatedly reactive on first-generation hepatitis C virus assays:justification and rational implementation.
    Tobler LH; Tegtmeier G; Stramer SL; Quan S; Dockter J; Giachetti C; Busch MP
    Transfusion; 2000 Jan; 40(1):15-24. PubMed ID: 10644807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody response to hepatitis C virus infection after liver transplantation.
    Hsu HH; Wright TL; Tsao SC; Combs C; Donets M; Feinstone SM; Greenberg HB
    Am J Gastroenterol; 1994 Aug; 89(8):1169-74. PubMed ID: 7519818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human antibodies to dengue and yellow fever do not react in diagnostic assays for hepatitis C virus.
    Yoshida CF; Rouzerè CD; Nogueira RM; Lampe E; Travassos-da-Rosa MA; Vanderborght BO; Schatzmayr HG
    Braz J Med Biol Res; 1992; 25(11):1131-5. PubMed ID: 1285268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Confirmation of second generation anti-hepatitis C virus enzyme immunoassays by antigenic cross-validation.
    Teo CG; Gabriel FG; Mortimer PP
    J Clin Pathol; 1992 Oct; 45(10):917-20. PubMed ID: 1331199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevalence of antibodies against hepatitis C virus in rheumatoid arthritis. Study using second-generation tests].
    Marson P; Vicarioto M; Cavasin F; Volante D; De Silvestro G
    Recenti Prog Med; 1991 Dec; 82(12):679-81. PubMed ID: 1667711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to hepatitis C virus in autologous blood donors.
    Conover PT; Fang CT; Lam E; Hirschler NV; Jackson JB; Yomtovian RA
    Transfusion; 1991 Sep; 31(7):616-9. PubMed ID: 1654002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C antibody after kidney transplantation: clinical significance.
    Marcen R; Gamez C; Mateos ML; Orofino L; Teruel JL; Serrano P; Pascual J; Quereda C; Nash R; Ortuño J
    Am J Nephrol; 1993; 13(3):184-9. PubMed ID: 7692726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.